Mycobacterium fortuitum ventriculoperitoneal shunt infection in an immunocompromised patient: A case report

Natalia Lattanzio; Stephen Bell; Victoria Campdesuner; Justin George; Talal Alkayali; Yorlenis Rodriguez; Wilhelmine Wiese-Rometsch; Natan Kraitman

doi:10.1016/j.idcr.2020.e00995

Mycobacterium fortuitum ventriculoperitoneal shunt infection in an immunocompromised patient: A case report

IDCases. 2020 Oct 23:22:e00995. doi: 10.1016/j.idcr.2020.e00995. eCollection 2020.

Authors

Natalia Lattanzio¹, Stephen Bell¹, Victoria Campdesuner¹, Justin George¹, Talal Alkayali¹, Yorlenis Rodriguez¹, Wilhelmine Wiese-Rometsch¹, Natan Kraitman²

Affiliations

¹ Internal Medicine, Sarasota Memorial Hospital, Sarasota, FL, USA.
² Infectious Disease, Sarasota Memorial Hospital, Sarasota, FL, USA.

Abstract

We present a case of Mycobacterium fortuitum ventriculoperitoneal shunt infection in a 26-year-old immunocompromised woman. The patient was treated with revision and replacement of her peritoneal shunt and prolonged combination antimicrobial therapy. There are no established guidelines for the treatment of VP shunt infections due to M. fortuitum. We review the literature and provide treatment recommendations.

Keywords: CNS, central nervous system; CT, computed tomography; Mycobacterium fortuitum; Rapidly growing mycobacteria; VP, ventriculoperitoneal shunt; Ventriculoperitoneal shunt.

Publication types

Case Reports